Stoke Therapeutics Revenue

Biotechnology Research • Bedford, Massachusetts, United States • 101-200 Employees

Stoke Therapeutics revenue & valuation

Annual revenue	$199,900,000
Revenue per employee	$1,290,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$639,700,000
Total funding	$230,100,000

Key Contacts at Stoke Therapeutics

Doug Snow

Director Of Communications & Investor Relations

Zach Thomas

Senior Director, Medical Affairs

Girija Raman Msc

Director Program Management

Arpita Patel

Director Of Quality

Tiffany Baerwaldt

Senior Director, Market Access Strategy & Marketing

Jayen Diyora

Director, Manufacturing Validation

Megha Kapur

Director, Program Management

Geno Clemenzi

Sr. Director, Regulatory Affairs

Christy Chaves Blaney

Senior Director, Head Of Talent Acquisition

Steven Gross

Senior Medical Director, Clinical Development - Ophthalmology

Company overview

Headquarters	45 Wiggins Ave, Bedford, Massachusetts 01730, US
Phone number	+17814308200
Website	stoketherapeutics.com
NAICS	541714
SIC	873
Founded	2017
Employees	101-200
Socials

Stoke Therapeutics Email Formats

Stoke Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@stoketherapeutics.com), used 77% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@stoketherapeutics.com	77%
{first initial}{last name}	jdoe@stoketherapeutics.com	23%

About Stoke Therapeutics

Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Director

Entry

Senior

Employees by Department

Stoke Therapeutics has 76 employees across 13 departments.

Departments

Number of employees

Funding Data

Explore Stoke Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-12-24	14	$105,100,000
2024-04-27	14	$125,000,000

Funding Insights

$230,100,000

Total funding amount

$125,000,000

Most recent funding amount

Number of funding rounds

Stoke Therapeutics Tech Stack

Discover the technologies and tools that power Stoke Therapeutics's digital infrastructure, from frameworks to analytics platforms.

PWA

Miscellaneous

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Draftpress HFCM

WordPress plugins

Google Tag Manager

Tag managers

Nginx

Reverse proxies

Frequently asked questions

Stoke Therapeutics is located in Bedford, Massachusetts, US.

You can reach Stoke Therapeutics at +17814308200.

Stoke Therapeutics generates an estimated annual revenue of $199,894,000. This revenue figure reflects the company's market position and business performance in its industry.

Stoke Therapeutics has an estimated valuation of $639,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Stoke Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Stoke Therapeutics has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Stoke Therapeutics has raised a total of $230,100,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.